Concepedia

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo, Riten Kumar, Ildar Nurmeev, Kerry Hege, Damien Bonnet, Philip Connor, Hélène L. Hooimeijer, Marcela Torres,

The Lancet Haematology · 2019 · 315 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.9K citations

, , +12

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2010 · 3.2K citations · Full text

, , +16

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

New England Journal of Medicine · 2012 · 2.3K citations · Full text

, , +15

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2013 · 1.9K citations · Full text

, , +13

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Scott Kaatz, Alex C. Spyropoulos, Sam Schulman · Journal of Thrombosis and Haemostasis · 2015 · 1.4K citations

, , +16